期刊文献+

人类白细胞抗原基因多态性与药物不良反应研究进展 被引量:10

Research progress on human leucocyte antigen gene polymorphisms and drug adverse reactions
下载PDF
导出
摘要 药物不良反应已成为危害人类健康的重要公共卫生问题。人类白细胞抗原基因(HLA)是目前已知的人类最复杂基因系统。近年来研究发现,人类白细胞抗原基因多态性与药物不良反应之间有着很强的遗传相关性,且部分研究成果在临床已得到很好地应用。本文就人类白细胞抗原基因多态性与药物不良反应之间的研究及其临床应用进行阐述。 Drug adverse reactions which are harmful to human health have become an impor- tant public health problem. Human leucocyte antigene is the most complex gene system. Re- cent years, research has demonstrated that there is a strong genetic link between HLA gene and drug adverse reactions. What's more, some re- search achievements have also been applied broadly in clinical practice. This review covers the progress between HLA polymorphisms and drug adverse reactions and on its clinical prac- tice.
作者 罗建权 张伟
出处 《中国临床药理学与治疗学》 CAS CSCD 2012年第7期828-834,共7页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金资助项目(30801421 30901834 81001476) 863计划(2009AA022710 2009AA022703 2012AA02A518) 教育部新世纪优秀人才支持计划(NCET-10-0843)
关键词 人类白细胞抗原基因(HLA) 药物不良反应 药物基因组学 Human leucocyte antigen (HLA) Drug adverse reactions Pharmacog- enomlcs
  • 相关文献

参考文献47

  • 1Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies [J]. JAMA, 1998, 279(15) :1200-1205.
  • 2陈旺青,张伟.撤市药物的遗传药理学[J].中国临床药理学与治疗学,2011,16(9):1065-1071. 被引量:2
  • 3Nakamura Y. Pharmacogenomics and drug toxicity [J].N EnglJ Med, 2008, 359(8):856-858.
  • 4Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multi- forme[J]. ArchDermatol, 1993, 129(1):92-96.
  • 5Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome [J]. Orphanet J RareDis ,2010,5:39-50.
  • 6Chung WH, Hung S I, Hong H S, et al. Medical genetics., a marker for Stevens-Johnson syndrome [J]. Nature, 2004, 428(6982):486.
  • 7Hung SI, Chung WH, Jee SH, et al. Genetic sus- ceptibility to carbamazepine-induced cutaneous ad- verse drug reactions[J]. Pharmacogenet Genomics, 2006, 16(4):297-306.
  • 8Mart CB, Kwan P, Baum L, et al. Association be- tween HLA-B 1502 allele and antiepileptic drug-in- duced cutaneous reactions in Han Chinese [J].Epi- lepsia, 2007, 48(5):1015-1018.
  • 9Locharernkul C, Loplumlert J, Limotai C, et al. Carbamazepine and phenytoin induced Stevens-John- son syndrome is associated with HLA-B : 1502 al- lele in Thai popuIation[[J]. Epil.epsia, 2008, 49 (12) :2087-2091.
  • 10Tassaneeyakul W, Tiamkao S, Jantararoungtong T, et al. Association between HLA-B * 1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population [[J]. Epilepsia, 2010, 51(5) :926-930.

二级参考文献65

  • 1魏伟.对临床药理学一些基本问题研究的思考[J].中国临床药理学与治疗学,2008,13(10):1081-1085. 被引量:12
  • 2杨剑,缪丽燕.华法林的基因组学研究进展[J].中国临床药理学与治疗学,2006,11(12):1326-1331. 被引量:11
  • 3Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies [J]. JAMA, 1998, 279(15): 1200- 1205.
  • 4Topoi EJ. Failing the public health-rotecoxib, Merck, and theFDA[J]. N Engl J Med,2004,351 (17) 1707-1709.
  • 5James WP, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in over- weight and obese subjects[J]. N Engl J Med,2010, 363(10) : 905-917.
  • 6Bae SK, Cao S, Seo KA, et al. Cytochrome P450 2B6 catalyzes the formation of pharmacologically ac- tive sibutramineN- { 1-[ 1- ( 4-chlorophenyl ) cyclobu- tyl]-3-methylbutyl} N, N-dimethylamine) metabo- lites in human liver microsomes[J]. Drug Metab Dispos,2008,36(8) : 1679-1688.
  • 7Chung JY, Jang SB, Lee YJ, et al. Effect of CYP2B6 genotype on the pharmacokinetics of sib- utramine and active metabolites in healthy subjects [J]. J ClinPharmacol,2011,51(1): 53-59.
  • 8Hsiao DJ, Wu LS, Huang SY, et al. Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene[J]. Pharmacogenet Genomics, 2009, 19 (9) : 730-733.
  • 9朱珠 孙忠实.阿洛司琼问市9个月即撤出市场.中国药学杂志,2001,36(3):211-211.
  • 10Camilleri M, Atanasova E, Carlson PJ, et al. Sero- tonin transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome[J]. Gastroenterology, 2002,123 (2) : 425 - 432.

共引文献1

同被引文献54

  • 1中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南(2011版)[J].中华临床感染病杂志,2011,4(6). 被引量:380
  • 2董淑婷,刘增娟,施兵奇.拉莫三嗪致过敏反应一例[J].临床误诊误治,2005,18(11):844-844. 被引量:4
  • 3田泽芬.别嘌醇治疗痛风的不良反应分析[J].中国药房,2006,17(11):849-849. 被引量:8
  • 4王聪华,陈丽娜,朱平,樊春梅,王彦宏,贾俊峰.CD147分子通过VEGF促进类风湿关节炎滑膜组织中的血管新生[J].细胞与分子免疫学杂志,2007,23(5):426-428. 被引量:17
  • 5沈晓明,王卫平.儿科学[M].7版.北京:人民卫生出版社,2008:93.
  • 6Chiu ML,Hu M,Ng MH,et al.Association between HLA-B*58:01allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong[J].Br J Dermatol,2012,167(1):44-49.
  • 7Cao ZH,Wei ZT,Zhu QY,et al.HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese[J].Pharmacogenomics,2012,13(10):1193-1201.
  • 8Jung JW,Song WJ,Kim YS,et al.HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency[J].Nephrol Dial Transplant,2011,26(11):3567-3572.
  • 9Hung S I,Chung W H,Liou L B,et al.HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol[J]. Proc Natl Acad Sci USA,2005,102(11):4134-4139.
  • 10Lonjou C,Borot N,Sekula P,et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs[J]. Pharmacogenomics Genomics,2008,18(2):99-107.

引证文献10

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部